HBeAg negative patients with chronic hepatitis B are less likely to have a biochemical breakthrough during lamivudine treatment

Akarca U. S. , Gunsar F., Ersoz G., Ozacar T., Erensoy S., Akyildiz M., ...More

40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, France, 13 - 17 April 2005, vol.42, pp.170 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 42
  • City: Paris
  • Country: France
  • Page Numbers: pp.170